Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
l�ll
Post-traumatic stress disorder: emerging concepts of pharmacotherapy Baker DG; Nievergelt CM; Risbrough VBExpert Opin Emerg Drugs 2009[Jun]; 14 (2): 251-72Post-traumatic stress disorder (PTSD) can result from a traumatic experience that elicits emotions of fear, helpless or horror. Most individuals remain asymptomatic or symptoms quickly resolve, but in a minority intrusive imagery and nightmares, emotional numbing and avoidance, and hyperarousal persist for decades. PTSD is associated with psychiatric and medical co-morbidities, increased risk for suicide, and with poor social and occupational functioning. Psychotherapy and pharmacotherapy are common treatments. Whereas, research supports the efficacy of the cognitive behavioral psychotherapies, there is insufficient evidence to unequivocally support the efficacy of any specific pharmacotherapy. Proven effective pharmacologic agents are sorely needed to treat core and targeted PTSD symptoms, and for prevention. This review describes current and emerging pharmacotherapies that advance these goals.|Adrenergic alpha-Antagonists[MESH]|Animals[MESH]|Anticonvulsants/therapeutic use[MESH]|Antidepressive Agents/therapeutic use[MESH]|Antipsychotic Agents/therapeutic use[MESH]|Benzodiazepines/therapeutic use[MESH]|Drug Delivery Systems[MESH]|Humans[MESH]|Psychotropic Drugs/*therapeutic use[MESH]|Stress Disorders, Post-Traumatic/diagnosis/*drug therapy/epidemiology[MESH] |